Cimetidine reduces impairment of cellular immunity after cardiac operations with cardiopulmonary bypass

Journal of Thoracic and Cardiovascular Surgery

Volumn 116, Issue 2, 1998, Pages 312-318

  Katoh, Junya ^a   Tsuchiya, Kouji ^b   Osawa, Hiroshi ^b   Sato, Wataru ^b   Matsumura, Gouki ^a   Iida, Yoshinao ^a   Suzuki, Shoji ^a   Hosaka, Shigeru ^a   Yoshii, Shinpei ^a   Tada, Yusuke ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b Yamanashi Prefectural Central Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CEFAZOLIN; CIMETIDINE;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; FEMALE; HEART VALVE SURGERY; HUMAN; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NATURAL KILLER CELL; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031818410     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/S0022-5223(98)70132-1     Document Type: Article

References (27)

1. A Markewitz, E Faist, S Lang, S Endres, D Fuchs, and B. Reichart Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation J Thorac Cardiovasc Surg 105 1993 15 24
2. E Faist, A Markewitz, and D Fuchs Immunomodulatory therapy with thymopentin and indomethacin: successful restoration of interleukin-2 synthesis in patients undergoing major surgery Ann Surg 214 1991 264 275
3. DM Nguyen, DS Mulder, and H. Shennib Effect of cardiopulmonary bypass on circulating lymphocyte function Ann Thorac Surg 53 1992 611 616
4. E Tønnesen, MM Brinkløv, NJ Christensen, AS Olesen, and T Madsen Natural killer cell activity and lymphocyte function during and after coronary artery bypass grafting in relation to the endocrine stress response Anesthesiology 67 1987 526 533
5. H Ide, T Kakiuchi, and N Furuta The effect of cardiopulmonary bypass on T cells and their subpopulations Ann Thorac Surg 44 1987 277 282
6. L DePalma, M Yu, CL McIntosh, JA Swain, and RJ. Davey Changes in lymphocyte subpopulations as a result of cardiopulmonary bypass: the effect of blood transfusion J Thorac Cardiovasc Surg 101 1991 240 244
7. S De Angeli, A Paccagnella, and M Mordacchini The effects of prolonged cardiopulmonary bypass on cell-mediated immunity Thorac Cardiovasc Surg 42 1994 14 20
8. K Hisatomi, T Isomura, and T Kawara Changes in lymphocyte subsets, mitogen responsiveness, and interleukin-2 production after cardiac operations J Thorac Cardiovasc Surg 98 1989 580 591
9. K Tajima, F Yamamoto, and K Kawazoe Cardiopulmonary bypass and cellular immunity: changes in lymphocyte subsets and natural killer cell activity Ann Thorac Surg 55 1993 625 630
10. H van Velzen-Blad, YJ Dijksta, CJ Heijnen, GA Schurink, BJM Zegers, and RE. Ballieux Cardiopulmonary bypass and host defense functions in human beings. II: Lymphocyte function Ann Thorac Surg 39 1985 212 217
11. RRM Gifford, and AF. Tirberg Histamine type-2 receptor antagonist immune modulation. II: Cimetidine and ranitidine increase interleukin-2 production Surgery 102 1987 242 247
12. RRM Gifford, BV Voss, JR Schmidtke, and RM. Ferguson Histamine type-2 receptor antagonist immune modulation. I: Increased cell-mediated cytotoxicity in normal and in downregulated systems Surgery 103 1988 184 192
13. DM Sahasrabudhe, CS McCune, RW O'Donnell, and EC Henshaw Inhibition of suppressor T lymphocytes (Ts) by cimetidine J Immunol 138 1987 2760 2763
14. A. Kumar Cimetidine: an immunomodulator Ann Pharmacother 24 1990 289 295
15. KB Hahm, WH Kim, SI Lee, JK Kang, and IS. Park Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients Scand J Gastroenterol 30 1995 265 271
16. S. Matsumoto Cimetidine and survival with colorectal cancer Lancet 346 1995 115
17. WJ Adams, and DL. Morris Short-course cimetidine and survival with colorectal cancer Lancet 344 1994 1768 1769
18. H Tonnesen, U Knigge, and S Bulow Effect of cimetidine on survival after gastric cancer Lancet ii 1988 990 991
19. CL Vecchia, E Negli, B D'Avanzo, and S Franceschi Histamine-2-receptor antagonists and gastric cancer risk Lancet 336 1990 355 357
20. RL Zapata-Sirvent, JF Hansbrough, EM Bender, EJ Bartle, MA Mansour, and WH. Carter Postburn immunosuppression in an animal model. IV: Improved resistance to septic challenge with immunomodulating drugs Surgery 99 1986 53 59
21. J Katoh, K Tsuchiya, W Sato, M Nakajima, and Y. Iida Cimetidine and immunoreactivity Lancet 348 1996 404 405
22. G. Rook Cell-mediated immune reactions 4th ed I Roitt, J Brostoff, D Male, Immunology. 1996 Mosby London 9 1-15
23. WJ Adams, JA Lawson, and DL. Morris Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth Gut 35 1994 1632 1636
24. RD Thornes, G Lynch, and MV. Sheehan Cimetidine and coumarin therapy of melanoma Lancet 2 1982 328
25. P Lydyard, and C. Grossi Cells involved in the immune response 4th ed I Roitt, J Brostoff, D Male, Immunology. 1996 Mosby London 2 7-8
26. DM Nguyen, DS Mulder, and H. Shennib Natural killer cell activity after cardiopulmonary bypass Ann Thorac Surg 58 1994 274 280
27. KL Melmon, HR Bourne, Y Weinstein, and M. Selma Receptors for histamine can be detected on the surface of selected leukocytes Science 177 1972 707 709